choroideremia-hypopituitarism syndrome
ORPHA: 14341 Treatment Available
Overview
human disease
Available Treatments (1)
| Drug | Form | Status | Countries | Lead Time |
|---|---|---|---|---|
| levothyroxine sodium | oral tablet, 25-300mcg | FDA Approved | 11 | 3d |
Classification & Codes
Orphanet Code
ORPHA:1434choroideremia-hypopituitarism syndrome
| Orphanet | ORPHA:1434 |
| Treatments | 1 drug(s) |
| Status | published |
Treatment Summary
Factual Authority
Last Updated3/20/2026
Clinical DataHPO · Orphanet
Drug DataFDA · EMA · CDSCO